FreeThink Technologies
Private Company
Total funding raised: $8M
Overview
FreeThink Technologies, founded in 2007 and headquartered in Easton, Connecticut, is a specialized service and software provider focused on pharmaceutical stability and formulation. Its core offering is the ASAPprime® software platform for accelerated stability studies, complemented by a full-service analytical laboratory for formulation development and stability testing. The company serves a global clientele, positioning itself as a critical partner in de-risking and accelerating drug development through predictive science. It is a privately held, revenue-generating business built on a services and platform model.
Technology Platform
ASAPprime® software for accelerated stability prediction and modeling, integrated with material-sparing experimental design and analysis.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
FreeThink competes with large, full-service CROs (like Charles River, Labcorp, PPD) that offer stability testing, but differentiates with its specialized ASAP expertise and proprietary software. It also faces competition from other niche stability consulting firms and software providers focused on predictive stability, though its integrated lab-software model and scientific reputation provide a strong market position.